I guess that's markets 101 right there. A lot of smoke and mirrors going on with all companies and getting investors across the line to believe and back it to go absolutely orbital!
this stock is largely held by retail investors and selling the dream of what it could be is more effective than giving a light touch on possibilities in my opinion which is then up to the market to assess how truthful these statements are and see if they can even get there - if they can even take a sliver of this ct:vq market, would that be a success?
I think the company is in a great spot with this fda approval, theyve been around the block a few times with the FDA and their ct lvas is a predicate device for the 510(K) approval - the easiest and most relaxed approval procvess within the FDA. I know the company has missed on guidance in the past, much to all of our disdain, but, they haven't slipped up with the FDA which is really what we SHOULD be caring about.
if / once the fda approval is approval itll all be kumbaya with andreas on these threads id imagine!
this company is often misclassified as an operating medical company when realistically this is a whiff of the appetiser... the main course is ct:vq which will really get the party started. with a great day of trading, the 55c options may certainly be in the money which will trigger even further cash to get this out the door in the hands of clinicians in the states.
gltah and go kangas
4DX Price at posting:
29.5¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)